Pain Niwaran Churna for treating Rheumatoid Arthritis and Osteoarthritis and Dr Relaxi capsule for Joints Pain which faced Maharashtra Food and Drug Administration (FDA) scrutiny for non-compliance to the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 (DMR Act) has finally got clearance from Pharmacopoeial Laboratory for Indian Medicine (PLIM).
The lab in its report stated that the said products conform to specifications and are of standard quality.
PLIM is a subordinate office of the Ministry of Health and Family Welfare, Department of Ayush. It is a standards setting cum drugs testing laboratory at national level for Indian medicines which include drugs of Ayurveda, Unani and Siddha systems.
Maharashtra FDA collected the samples of Pain Niwaran Churna and Dr Relaxi capsule following a raid at Rajasthan Aushadhalaya Pvt Ltd in Mumbai and claimed that the samples were not of standard (NSQ) quality.
“Further to this, the samples of the products in question were sent to PLIM based on the directions of Maharashtra FDA. The lab results cleared the allegations of false claims about the products and stated that they are of standard quality”, explained a company official referring to the lab results report reviewed by Pharmabiz.
Rajasthan Aushadhalaya is a 65 years old company manufacturing ayurvedic, herbal, nutraceutical and cosmetic products. It started with manufacturing de-addiction products and today has a product portfolio of 65 products. By 2020, the company plans to come out with 12 new products.
To curb rampant violations of DMR act, the state regulator recently raided and seized spurious drugs worth Rs.11 lac from retail outlets of 13 ayurvedic manufacturers in Maharashtra. These companies have manufacturing base in Uttarakhand, Punjab, Jammu & Kashmir, Rajasthan, Madhya Pradesh, Gujarat and Maharashtra.
The DMR Act, 1954 is an Act of the Parliament of India which controls advertising of drugs in India. It prohibits advertisements of drugs and remedies that claim to have magical properties and makes doing so a cognizable offense.
The law prohibits advertising of drugs and remedies for inducing miscarriage or preventing conception in women, improving or maintaining the capacity for sexual pleasure, correction of menstrual disorders, curing, diagnosing or preventing any disease or condition among others.
The Act defines magic remedy as any talisman, mantra, amulet or any other object which is claimed to have miraculous powers to cure, diagnose, prevent or mitigate a disease in humans or animal. It also includes such devices that are claimed to have power to influence structure or function of an organ in humans or animals.